Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Prof Marella de Bruijn, awarded the title of full professor of Developmental Haematopoiesis in the recent Recognition of Distinction Exercise.

Headshot of Marella de Bruijn

This is a huge achievement and reflects not only her research achievements but also commitment to teaching and ‘good citizenship’.

Prof Marella de Bruijn leads a team investigating the cellular and molecular mechanisms that underlie the generation and maintenance of haemopoietic stem cells (HSCs). Marella is currently the Chair of the MRC WIMM Graduate Studies committee, and Director of Graduate Studies for the Radcliffe Department of Medicine and the Director of the Oxford-MRC Doctoral Training Partnership.

Similar stories

Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing

The biotechnology company builds upon research conducted by Professor Jim Hughes and Prof. James Davies at the MRC Weatherall Institute of Molecular Medicine, and combines 3D genome technology and machine learning to decode the dark matter of the human genome.

KJ Patel appointed new Chief Scientist of CRUK

Alongside his new role at Cancer Research UK, Prof. Patel will continue as the Director of both the MRC Weatherall Institute for Molecular Medicine (MRC WIMM) and the MRC Molecular Haematology Unit (MRC MHU).

September is Childhood Cancer Awareness Month

September is Childhood Cancer Awareness Month, where our Childhood Leukaemia research group have taken action to help raise awareness for this cause.

Wellcome Trust funding success for Jim Hughes and James Davies

£3.6 million in funding awarded by the Wellcome Trust to combine cutting-edge 3D genome technologies with machine learning approaches to decipher the role of the non-coding genome in disease.